The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge
Open accessAbstract
While the incidence of gastric cancer has decreased worldwide in recent decades, the incidence of signet-ring cell carcinoma (SRCC) is rising. SRCC has a specific epidemiology and oncogenesis and has two forms: early gastric cancer, which can be resected endoscopically in some cases and which has a better outcome than non-SRCC, and advanced gastric cancer, which is generally thought to have a worse prognosis and lower chemosensitivity than non-SRCC. However, the prognosis of SRCC and its chemosensitivity with specific regimens are still controversial as SRCC is not specifically identified in most studies and its poor prognosis may be due to its more advanced stage. It therefore remains unclear if a specific therapeutic strategy is justified, as the benefit of perioperative chemotherapy and the value of taxane-based chemotherapy are unclear. In this review we analyze recent data on the epidemiology, oncogenesis, prognosis and specific therapeutic strategies in both early and advanced SRCC of the stomach and in hereditary diffuse gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Wilke, H., Muro, K., Van Cutsem, E., Oh, S.-C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,438
Fuchs, C. S., Tomasek, J., Yong, C. J., Dumitru, F., Passalacqua, R., Goswami, C., Safran, H., dos Santos, L. V., Aprile, G., Ferry, D. R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61719-5 · Cited by 2,188
Gotoda, T., Yanagisawa, A., Sasako, M., Ono, H., Nakanishi, Y., Shimoda, T., & Kato, Y. (2000) · Gastric Cancer · doi:10.1007/pl00011720 · Cited by 1,791
Songun, I., Putter, H., Kranenbarg, E. M.-K., Sasako, M., & van de Velde, C. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70070-x · Cited by 1,765
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
E-cadherin germline mutations in familial gastric cancer
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., & Reeve, A. E. (1998) · Nature · doi:10.1038/32918 · Cited by 1,656
for the Surgical Co-operative Group, Cuschieri, A., Weeden, S., Fielding, J., Bancewicz, J., Craven, J., Joypaul, V, Sydes, M., & Fayers, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690243 · Cited by 1,373
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
Cavallaro, U., & Christofori, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1276 · Cited by 1,311
Hartgrink, H. H., van de Velde, C. J. H., Putter, H., Bonenkamp, J. J., Klein Kranenbarg, E., Songun, I., Welvaart, K., van Krieken, J. H. J. M., Meijer, S., Plukker, J. T. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.026 · Cited by 918
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond
Hansford, S., Kaurah, P., Li-Chang, H., Woo, M., Senz, J., Pinheiro, H., Schrader, K. A., Schaeffer, D. F., Shumansky, K., Zogopoulos, G., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2014.168 · Cited by 694
van der Post, R. S., Vogelaar, I. P., Carneiro, F., Guilford, P., Huntsman, D., Hoogerbrugge, N., Caldas, C., Chelcun Schreiber, K. E., Hardwick, R. H., Ausems, M. G. E. M., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103094 · Cited by 561
Fitzgerald, R. C., Hardwick, R., Huntsman, D., Carneiro, F., Guilford, P., Blair, V., Chung, D. C., Norton, J., Ragunath, K., Van Krieken, J. H., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.074237 · Cited by 542
Gastric carcinoma:A pathobiological classification
Ming, S.-C. (1977) · Cancer · doi:10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l · Cited by 531
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., Wiesner, G., Ferguson, K., Eng, C., Park, J.-G., et al. (2000) · Nature Genetics · doi:10.1038/79120 · Cited by 447
Henson, D. E., Dittus, C., Younes, M., Nguyen, H., & Albores-Saavedra, J. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-765-dtitia · Cited by 402
Brooks-Wilson, A. R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y. S. N., Jeyes, J., Schinas, J., Bacani, J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018275 · Cited by 361
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review
Chiurillo, M. A. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.84 · Cited by 317
Piessen, G., Messager, M., Leteurtre, E., Jean-Pierre, T., & Mariette, C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b21c7b · Cited by 316
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
Machado, J. C., Oliveira, C., Carvalho, R., Soares, P., Berx, G., Caldas, C., Seruca, R., Carneiro, F., & Sobrinho-Simöes, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204234 · Cited by 278
Germline CDH1 deletions in hereditary diffuse gastric cancer families
Oliveira, C., Senz, J., Kaurah, P., Pinheiro, H., Sanges, R., Haegert, A., Corso, G., Schouten, J., Fitzgerald, R., Vogelsang, H., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp046 · Cited by 217
Pathology and prognosis of gastric carcinoma: Well versus poorly differentiated type
Adachi, Y., Yasuda, K., Inomata, M., Sato, K., Shiraishi, N., & Kitano, S. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1418::aid-cncr2>3.0.co;2-a · Cited by 204
Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi, Y., Yasuda, K., Inomata, M., Sato, K., Shiraishi, N., & 正剛, 北. (2000) · PubMed · Cited by 182
E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
Humar, B., Blair, V., Charlton, A., More, H., Martin, I., & Guilford, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2457 · Cited by 170
Graziano, F., Humar, B., & Guilford, P. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg486 · Cited by 168
Benusiglio, P. R., Malka, D., Rouleau, É., Pauw, A. D., Buecher, B., Noguès, C., Fourme, E., Colas, C., Coulet, F., Warcoin, M., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101472 · Cited by 166
Longterm outcomes after endoscopic mucosal resection for early gastric cancer
Uedo, N., Iishi, H., Tatsuta, M., Ishihara, R., Higashino, K., Takeuchi, Y., Imanaka, K., Yamada, T., Yamamoto, S., Yamamoto, S., et al. (2006) · Gastric Cancer · doi:10.1007/s10120-005-0357-0 · Cited by 164
Survival After Gastric Adenocarcinoma Resection: Eighteen-Year Experience at a Single Institution
Cunningham, S. C., Kamangar, F., Kim, M. P., Hammoud, S., Haque, R. M., Maitra, A., Montgomery, E. A., Heitmiller, R. E., Choti, M. A., Lillemoe, K. D., et al. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.12.002 · Cited by 148
Lutz, M. P., Zalcberg, J. R., Ducreux, M. P., Ajani, J. A., Allum, W., Aust, D., Bang, Y., Cascinu, S., Hölscher, A. H., Jankowski, J. A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.07.029 · Cited by 146
Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach
Kwon, K.-J., Shim, K., Song, E.-M., Choi, J.-Y., Kim, S., Jung, H., & Jung, S.-A. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0234-1 · Cited by 145
Helicobacter pylori‐negative gastric cancer: Characteristics and endoscopic findings
Yamamoto, Y., Fujisaki, J., Omae, M., Hirasawa, T., & Igarashi, M. (2015) · Digestive Endoscopy · doi:10.1111/den.12471 · Cited by 132
Muro, K., Bang, Y., Shankaran, V., Geva, R., Catenacci, D. V. T., Gupta, S., Eder, J. P., Berger, R., Gonzalez, E. J., Ray, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.3_suppl.3 · Cited by 118
Estrogen receptor β is expressed in human stomach adenocarcinoma
Matsuyama, S., Ohkura, Y., Eguchi, H., Kobayashi, Y., Akagi, K., Uchida, K., Nakachi, K., Gustafsson, J.-Α., & Hayashi, S. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0336-3 · Cited by 117
van der Post, R. S., Vogelaar, I. P., Manders, P., van der Kolk, L. E., Cats, A., van Hest, L. P., Sijmons, R. H., Aalfs, C. M., Ausems, M. G. E. M., Gómez-García, E. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.003 · Cited by 91
Expression of estrogen receptors in gastric cancer and their clinical significance
Ryu, W., Kim, J., Jang, Y. J., Park, S. S., Um, J.-W., Park, S., Kim, S., Mok, Y., & Kim, C. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23097 · Cited by 87
Germline Mutations in MAP3K6 Are Associated with Familial Gastric Cancer
Gaston, D., Hansford, S., Oliveíra, C., Nightingale, M., Pinheiro, H. C., Macgillivray, C., Kaurah, P., Rideout, A. L., Steele, P., Soares, G., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004669 · Cited by 75
Bang, Y., Chung, H.-C., Shankaran, V., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.4001 · Cited by 45
Chu, C., Chen, C., Chan, D., Wu, H., Liu, Y., Shen, C., Chang, T.-M., Yu, J., Harn, H., Yu, C., et al. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-80 · Cited by 29
Hultman, B., Mahteme, H., Sundbom, M., Ljungman, M., Larsson, R. L., & Nygren, P. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0110-9 · Cited by 25
Pernot, S., Mitry, E., Samalin, E., Dahan, L., Dalban, C., Ychou, M., Seitz, J., Turki, H., Mazard, T., Zaanan, A., et al. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0266-6 · Cited by 21
Self-citationKim, S. C. H., Fiteni, F., Paget‐Bailly, S., Ghiringhelli, F., Lakkis, Z., Jary, M., Fein, F., Bonnetain, F., Mariette, C., & Borg, C. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0148-y · Cited by 17
Association of Genetic Variants in and Promoter Hypermethylation of CDH1 With Gastric Cancer
Jing, H., Dai, F., Zhao, C., Yang, J., Li, L., Kota, P., Mao, L., Xiang, K., Zheng, C.-Q., & Yang, J. (2014) · Medicine · doi:10.1097/md.0000000000000107 · Cited by 13
Cited by
Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., & Sitarz, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114012 · Cited by 1,520
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Qi, C., Gong, J., Li, J., Liu, D., Qin, Y., Ge, S., Zhang, M., Peng, Z., Zhou, J., Cao, Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01800-8 · Cited by 604
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z.-N., Teng, Q.-X., Tian, Q., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z.-S., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 322
Metadata
- Authors
- Pernot, S.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 21
- Issue
- 40
- Pages
- 11428
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2360734399
- Cited by
- 314
- References
- 45
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.